• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者脑脊液中SNAP-25水平升高。

Elevated cerebrospinal fluid SNAP-25 in schizophrenia.

作者信息

Thompson Peter M, Kelley Mary, Yao Jeffrey, Tsai Guochuan, van Kammen Daniel P

机构信息

Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

出版信息

Biol Psychiatry. 2003 Jun 15;53(12):1132-7. doi: 10.1016/s0006-3223(02)01599-8.

DOI:10.1016/s0006-3223(02)01599-8
PMID:12814864
Abstract

BACKGROUND

Research suggests an association between abnormal exocytosis and schizophrenia. We previously demonstrated increased synaptosomal associated protein, 25 kDa (SNAP-25), a member of the exocytotic mechanism, in the cerebrospinal fluid (CSF) of schizophrenia subjects. In this study, we explored SNAP-25 level and clinical variables in a new group of subjects.

METHODS

Twenty-five haloperidol-treated subjects with chronic schizophrenia and twenty-five healthy control subjects participated in the study. Subjects received haloperidol treatment for at least 3 months and then had a lumbar puncture (n = 19). Medication was replaced by placebo, and the lumbar puncture was repeated (n = 25) after 6 weeks or sooner if limited psychotic symptoms occurred. We measured the level of SNAP-25 in the CSF and symptoms with the Brief Psychiatric Rating Scale (BPRS).

RESULTS

In both haloperidol (p =.001) and placebo (p =.001) treatment conditions, SNAP-25 was elevated. There was no significant difference in SNAP-25 level between conditions. We identified significant positive correlations among SNAP-25 and the BPRS total score and psychosis and thinking disturbance subscales in subjects on haloperidol.

CONCLUSIONS

These observations confirm our previous report of elevated CSF SNAP-25 and suggest that synaptic pathology may be linked with the pathophysiology of schizophrenia.

摘要

背景

研究表明异常胞吐作用与精神分裂症之间存在关联。我们先前证明,精神分裂症患者脑脊液(CSF)中胞吐机制成员之一的突触体相关蛋白25 kDa(SNAP - 25)有所增加。在本研究中,我们在一组新的受试者中探究了SNAP - 25水平和临床变量。

方法

25名接受氟哌啶醇治疗的慢性精神分裂症患者和25名健康对照受试者参与了该研究。受试者接受氟哌啶醇治疗至少3个月,然后进行腰椎穿刺(n = 19)。药物被安慰剂替代,若出现有限的精神病性症状,则在6周或更早时间重复进行腰椎穿刺(n = 25)。我们用简明精神病评定量表(BPRS)测量脑脊液中SNAP - 25的水平和症状。

结果

在氟哌啶醇(p =.001)和安慰剂(p =.001)治疗条件下,SNAP - 25均升高。两种条件下SNAP - 25水平无显著差异。我们发现接受氟哌啶醇治疗的受试者中,SNAP - 25与BPRS总分、精神病性及思维障碍分量表之间存在显著正相关。

结论

这些观察结果证实了我们之前关于脑脊液中SNAP - 25升高的报告,并表明突触病理学可能与精神分裂症的病理生理学有关。

相似文献

1
Elevated cerebrospinal fluid SNAP-25 in schizophrenia.精神分裂症患者脑脊液中SNAP-25水平升高。
Biol Psychiatry. 2003 Jun 15;53(12):1132-7. doi: 10.1016/s0006-3223(02)01599-8.
2
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.在精神分裂症的抗精神病治疗中,SNAP-25基因可能与临床反应及体重增加有关。
Neurosci Lett. 2005 May 6;379(2):81-9. doi: 10.1016/j.neulet.2004.12.037. Epub 2005 Jan 26.
3
CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study.精神分裂症和双相情感障碍中的脑脊液SNAP-25。一项初步研究。
Neuropsychopharmacology. 1999 Dec;21(6):717-22. doi: 10.1016/S0893-133X(99)00068-8.
4
Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.“思瑞康”(喹硫平)多固定剂量用于精神分裂症急性加重患者:与氟哌啶醇和安慰剂的比较。思瑞康试验13研究组
Biol Psychiatry. 1997 Aug 15;42(4):233-46. doi: 10.1016/s0006-3223(97)00190-x.
5
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.氯氮平与氟哌啶醇治疗中度难治性精神分裂症:一项为期6个月的随机双盲对照研究
Arch Gen Psychiatry. 2001 Oct;58(10):965-72. doi: 10.1001/archpsyc.58.10.965.
6
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.舍吲哚与氟哌啶醇治疗精神分裂症的对照、剂量反应研究。舍吲哚研究组。
Am J Psychiatry. 1997 Jun;154(6):782-91. doi: 10.1176/ajp.154.6.782.
7
Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.
Schizophr Res. 1994 Apr;12(1):43-51. doi: 10.1016/0920-9964(94)90083-3.
8
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Biol Psychiatry. 1989 Jun;26(2):176-88. doi: 10.1016/0006-3223(89)90021-8.
9
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.早期精神病的口服与注射用抗精神病药物治疗:两项研究的事后比较
Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.
10
Risperidone in treatment-refractory schizophrenia.利培酮治疗难治性精神分裂症。
Am J Psychiatry. 1999 Sep;156(9):1374-9. doi: 10.1176/ajp.156.9.1374.

引用本文的文献

1
Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophrenia.重度抑郁症和精神分裂症患者脑脊液中突触蛋白SNAP-25减少的证据。
BMJ Ment Health. 2025 Aug 21;28(1):e301752. doi: 10.1136/bmjment-2025-301752.
2
Schizophrenia and Glutathione: A Challenging Story.精神分裂症与谷胱甘肽:一个具有挑战性的故事。
J Pers Med. 2023 Oct 25;13(11):1526. doi: 10.3390/jpm13111526.
3
Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis.
精神障碍患者与健康对照者脑脊液中的生物标志物:系统评价和荟萃分析。
Mol Psychiatry. 2023 Jun;28(6):2277-2290. doi: 10.1038/s41380-023-02059-2. Epub 2023 May 11.
4
Dynamic Changes of Brain Cilia Transcriptomes across the Human Lifespan.人类一生中脑纤毛转录组的动态变化。
Int J Mol Sci. 2021 Sep 27;22(19):10387. doi: 10.3390/ijms221910387.
5
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.首发精神病患者脑脊液中突触体相关蛋白25和突触结合蛋白-1的水平
IBRO Rep. 2020 Apr 13;8:136-142. doi: 10.1016/j.ibror.2020.04.001. eCollection 2020 Jun.
6
A Multilevel Functional Study of a At-Risk Variant for Bipolar Disorder and Schizophrenia.双相情感障碍和精神分裂症风险变异体的多层次功能研究。
J Neurosci. 2017 Oct 25;37(43):10389-10397. doi: 10.1523/JNEUROSCI.1040-17.2017. Epub 2017 Oct 2.
7
Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease.散发性克雅氏病患者脑脊液中潜在突触囊泡循环生物标志物的蛋白质组分析。
Mol Neurobiol. 2017 Sep;54(7):5177-5191. doi: 10.1007/s12035-016-0029-6. Epub 2016 Aug 25.
8
Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.ACPP基因的变异与脑脊液中前列腺酸性磷酸酶水平相关。
BMC Genomics. 2016 Jun 29;17 Suppl 3(Suppl 3):439. doi: 10.1186/s12864-016-2787-y.
9
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.SNAP-25是一种很有前景的新型脑脊液生物标志物,用于检测阿尔茨海默病中的突触退化。
Mol Neurodegener. 2014 Nov 23;9:53. doi: 10.1186/1750-1326-9-53.
10
Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.跨膜前列腺酸性磷酸酶缺陷的小鼠表现出γ-氨基丁酸能传递增加和神经学改变。
PLoS One. 2014 May 20;9(5):e97851. doi: 10.1371/journal.pone.0097851. eCollection 2014.